Icrucumab

Tax included
Icrucumab (Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1) is a humanized Anti-VEGFR-1 IgG1 monoclonal antibody. Icrucumab has the potential for the research of advanced solid tumors.
MedChemExpress 
HY-P99364

Data sheet

Size
Multiple sizes
Reactivity
VEGFR
Application
Cancer-Kinase/protease
CAS
1024603-92-6